ACETO CORPORATION (NASDAQ:ACET) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement.

On December 13, 2017, Aceto Corporation (the “Company”) entered into a First Amendment to Second Amended and Restated Credit Agreement (the “Amendment”), by and among the Company, certain other loan parties party thereto (the “Loan Parties”), the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent (the “Administrative Agent”), which amended that certain Second Amended and Restated Credit Agreement (the “A&R Credit Agreement”), dated as of December 21, 2016, by and among the Company, the Loan Parties, the lenders party thereto and the Administrative Agent.

The Amendment, among other things, contains several amendments to the financial covenants in the A&R Credit Agreement. The Total Net Leverage Ratio (as defined in the A&R Credit Agreement) was revised so that it shall not exceed 4.50 to 1.00 through the period ending June 30, 2018, rather than 4.50 to 1.00 for the four full fiscal quarters following December 21, 2016 (the “Effective Date”). The Senior Secured Net Leverage Ratio (as defined in the A&R Credit Agreement) was decreased so that it shall not exceed 2.75 to 1.00 through the period ending June 30, 2018, rather than 3.00 to 1.00 for the four full fiscal quarters following the Effective Date.

The foregoing description of the Amendment is a summary only, and is qualified in its entirety by reference to the complete text thereof, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K, and which is incorporated herein.

(a) Exhibits:

ACETO CORP Exhibit
EX-10.1 2 tv481482_ex10-1.htm EXHIBIT 10.1   Exhibit 10.1   Execution Version   FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT   This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is dated as of December 13,…
To view the full exhibit click here

About ACETO CORPORATION (NASDAQ:ACET)

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.